Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944)
- Citation:
- Breast Cancer Res Treat vol 113 (3) 479-490
- Year:
- 2009
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- U10 CA047577, U10 CA032291, U10 CA035279, U10 CA045808, U10 CA031946, CA77651, U10 CA033601, CA60138, U10 CA035421, U10 CA077440, U10 CA041287, U10 CA077651, U10 CA003927
- Corr. Author:
- Authors:
- G. G. Kimmick C. Cirrincione D. B. Duggan K. Bhalla N. Robert D. Berry L. Norton S. Lemke I. C. Henderson C. Hudis E. Winer
- Networks:
- Study
- Alliance-8944
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- Keywords:
- Breast cancer, Chemotherapy, Locally advanced, Long-term follow-up, Neoadjuvant, Stage III